Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBurping on Mounjaro is one of the most common digestive complaints, and for most people it traces back to one thing: the medicine slows how quickly food leaves your stomach, which means gas has more time to build. The good news is that a handful of straightforward changes to eating habits can reduce it significantly. Mounjaro (tirzepatide) is a prescription-only medicine, so any adjustments to how you manage side effects are worth raising with your prescriber — but the practical steps below are grounded in what is known about how the medicine works, and in NHS guidance on tirzepatide.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GIP and GLP-1 receptors, two gut-hormone pathways involved in regulating appetite and digestion. One of the direct effects is slowed gastric emptying: food moves out of the stomach more gradually than it would otherwise. That is genuinely useful for appetite control, but it also gives gas more opportunity to accumulate, and the result, for many people, is frequent belching.
It is worth knowing that this is not unique to Mounjaro. Semaglutide produces a similar effect for the same reason. But because tirzepatide often produces stronger appetite suppression, some people find the digestive symptoms feel more noticeable, particularly in the early weeks. A question our prescribers hear most weeks is whether the burping means something is wrong: it almost never does, but it is uncomfortable enough that people want practical answers rather than reassurance alone.
The pattern matters here. Burping is typically worst in the 48 to 72 hours after an injection, and again after a dose increase, and our dedicated guide to Mounjaro burping explains in detail why that timing happens and what drives the symptom at each stage. If it is fading by the end of the week, that is the expected trajectory. If it is getting worse over several weeks or arriving with pain, that is a different picture, covered below.
For a broader view of what to expect digestively, the full side-effects overview for Mounjaro sets out the whole range and how they typically behave over time.
Most of what works comes down to reducing how much air enters the stomach and slowing the rate at which food arrives there.
Eat more slowly than feels natural. Tirzepatide already reduces your appetite, which can paradoxically make people eat faster when they finally feel hungry, then feel overfull almost immediately. Taking smaller bites and pausing between them gives your stomach time to signal fullness before you overshoot. Overeating is one of the most reliable triggers for a surge in belching on this medicine.
Cut back on carbonated drinks. Fizzy water, sparkling mixers, and fizzy soft drinks introduce gas directly into a stomach that is already not moving quickly. Even small volumes can produce significant belching. Plain still water is the easiest swap.
Smaller, more frequent meals beat large ones. A full stomach pushes gas up; a steadily fed stomach does not. Many people on Mounjaro naturally drift toward smaller portions anyway, and leaning into that pattern rather than fighting it often eases digestive symptoms across the board.
Avoid eating close to lying down. Digestion slows further when you are horizontal, and gas finds upward routes more easily. Leaving two to three hours between eating and going to bed is a practical adjustment.
Some people find that gassy foods (carbonated drinks aside) make things worse: onions, cabbage, pulses, and certain artificial sweeteners can all contribute, and if you want a structured approach to tackling these triggers, our page on how to stop Mounjaro burps walks through each strategy in practical detail. This varies between individuals, so a brief food diary around injection days can help you spot personal patterns.
If you are weighing up the costs of private treatment while managing side effects, the Mounjaro price comparison page sets out what different providers include in their pricing.
For the vast majority of people, frequent belching on tirzepatide is an annoyance rather than a medical concern. There are, however, a handful of situations where symptoms warrant prompt medical attention.
In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines, including tirzepatide, highlighting acute pancreatitis as an infrequent but serious side effect. The key symptom to know is severe, persistent abdominal pain that may radiate toward the back, sometimes accompanied by vomiting. That combination is distinct from ordinary post-injection burping. If you experience it, stop eating and get medical help the same day; do not wait for your next prescriber review. The MHRA Yellow Card scheme allows patients to report suspected side effects directly.
Gallbladder symptoms are another category worth knowing. Rapid weight loss of any kind can increase gallstone risk, and pain in the upper right abdomen, particularly after eating fatty food, is different from the belching pattern described earlier. Worth mentioning to a GP if it appears.
Severe vomiting or diarrhoea alongside burping can cause dehydration, which has its own complications. If you cannot keep fluids down for more than 24 hours, that is a reason to seek same-day medical advice.
You can read more about the broader safety picture on the page covering Mounjaro's adverse effects, which goes into each category in more detail.
For most people, yes. The gastrointestinal side effects of tirzepatide are front-loaded: they are most pronounced in the first one to three weeks after starting and after each dose increase, then they settle as the body adapts to the new pace of digestion.
Clinical trial data supports this pattern. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, GI side effects were most common early in treatment and at escalation points. Most participants who experienced them reported improvement without stopping treatment.
Where burping persists beyond a couple of weeks at a stable dose, it is worth reviewing eating habits systematically rather than assuming the medicine is simply not suiting you. Portion size, eating speed, and drink choices are the three levers most worth adjusting first. If none of those help, that is a reasonable thing to discuss with your prescriber before any decision about continuing or adjusting the dose.
If you are still finding your feet with the treatment generally, the Mounjaro overview page covers how the medicine works and what the full titration journey typically looks like. And if you have specific questions about your own situation, our prescribers review consultations the same day, speak to our prescribers to get a clinical view on what you are experiencing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.